Dental Care Clinics in Ralston, NE Accepting Medicare
1 Dental Care Clinics found. Showing 1 - 1
 Spring Valley Dental Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 5360 S 72nd St, Ralston, NE 68127 Phone: 402-733-4441 Fax: 402-733-5863 |
News Archive
Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors
Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors.
Allowing optometrists to perform surgeries may put patients at risk
Proposed regulations for a new state law which allows optometrists, who are not medical doctors, to perform a broad range of surgical procedures on the eye, fail to properly define the education, training and oversight necessary for this new scope of work that is typically performed by medical board-certified physicians.
Lumenis announces launch of the AcuPulse Fractional CO2 Laser System for Aesthetics
Lumenis Inc., a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic applications, announced today the launch of the AcuPulse(TM) Fractional CO2 Laser System for aesthetic applications at the American Society of Dermatologic Surgery's annual meeting in Phoenix this week.
Renowned scientists recover deleted SARS-CoV-2 data from Wuhan
Renowned evolutionary researcher, Jesse Bloom from the Fred Hutchinson Cancer Research Center, has conducted a phylogenetic analysis suggesting that the early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequences that were obtained from the Huanan Seafood Market in Wuhan, China, are not fully representative of the viruses circulating in the city at the time of the coronavirus disease 2019 (COVID-19) outbreak.
Arsanis closes Series A financing for $10 million
Arsanis, Inc, a recently founded biotechnology company dedicated to the development of anti-infective monoclonal antibody therapeutics, today announced the closing of a Series A financing with a total funding amount of $10 million. Proceeds from the initial financing will be used to advance several programs in the anti-microbial infectious disease area.
› Verified 1 days ago